IBAB:EBR
Ion Beam Applications SA
€15.66
arrow_downward
-0.25%(-0.040) 1D
Sep 4, 5:35:16 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IBAB...
Open
€15.70
High
€15.94
Low
€15.60
Mkt. cap
480.16M
Avg. vol.
21.96K
Volume
28.22K
Dividend
1.12%
Quarterly dividend
€0.04
Ex-dividend date
Jun 15, 2026
P/E ratio
37.26
52-wk high
€17.76
52-wk low
€9.90
EPS
€0.42
Shares outstanding
30.28M
No. of employees
2K
Open
€15.70
High
€15.94
Low
€15.60
Mkt. cap
480.16M
Avg. vol.
21.96K
Volume
28.22K
Dividend
1.12%
Quarterly dividend
€0.04
Ex-dividend date
Jun 15, 2026
P/E ratio
37.26
52-wk high
€17.76
52-wk low
€9.90
EPS
€0.42
Shares outstanding
30.28M
No. of employees
2K
News stories
From web sources and news partners
GuruFocus
·
22 hours ago
Ion Beam Applications SA (IOBCF) (H1 2026) Earnings Call Highlig
Profile
IBA is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain and became a university spin-off. It employs about 1500 people in 40 locations. The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation.
IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001, and for University of Pennsylvania's Proton Center in 2009.
It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom.
In 2017, IBA invested €16 million in the construction of a new logistics and production center in Louvain-la-Neuve. Wikipedia
About Ion Beam Applications SA
CEOOlivier Legrain
Employees2.04K
Founded1986
Headquarters-
SectorMedical device
Websiteiba-worldwide.com